M3 Insurance’s Post

(STAT) - "Weight Loss Drugs Aren’t Covered By Obamacare. That May Change." Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. Finally AFFORDABLE Health Insurance Plans At: HI4E.org #ObamacarePlanRestrictions #ObamacareLimitedProviderNetworks #ObamacareLimitedMedications #HarmsOfOzempic #MedicarePartDDrugs #MedicareDrugCoverage #Wegovy #Ozempic #Tirzepatide #AffordableDrugs #WeightLossDrugTirzepatide #FatBodies #WeightLossDrugs #Obesity #EliLillyWeightLossDrug #WeightLossShot #ObesityDrugs #WeightLossInjections #MedicareObesityDrugs #WeightLossPrescriptions #WeightControl #OzempicSideEffects #HI4E.Org #HealthAndLifeSolutions #Mounjaro #OverweightPeople #WeightLoss #CalorieCounting #Obesity #OverweightAdults #ObeseSeniors #HealthyLivingTips #WeightWatchers #HealthInsuranceForEveryone #Stat

You have likely heard about emerging weight loss drugs, but do you know what the cost is for your company? Join us for a webinar to learn more! On average, these drugs are priced over $10,000 per member annually. In many cases, your employees incur a fraction of the cost out of pocket while the company’s health plan costs continue to increase. Total pharmacy benefit spend for employers has reached an average of 30-35% of your total health insurance cost and that share is growing quickly. What can you do to control costs and maintain strong pharmacy benefits for your employees? Join us for our upcoming webinar where we will discuss the following: - Overview of prescription cost drivers like GLP-1s, Gene therapies, and Biosimilar prescription drugs - Proven strategies to reduce prescription benefit costs - Best practices for ongoing pharmacy benefit management #pharmacy #rx #employeebenefits #healthinsurance

To cover or not is the question many U.S. insurance companies and employers continue to ponder when it comes to obesity medications, such as Wegovy, and diabetes drugs, like Ozempic and Mounjaro, being used off-label for weight loss. Click below to learn more. https://lnkd.in/g_tSE5Ku #weightloss #healthinsurance #employeebenefits

Summary: Employers, insurers, and Medicare are facing pressure to cover weight-loss drugs, but many are not yielding, making it difficult for individuals to access these expensive treatments. The cost of these drugs is a significant barrier, leading to limited coverage and restrictions on access. Takeaway: Access to weight-loss drugs remains limited due to high costs, with employers and insurers making it even harder for individuals to obtain coverage. The future introduction of competing treatments and oral versions may help drive prices down and improve access. Hashtags: #Healthcare #Insurance #Medicare #WeightLossDrugs #Pharma #ObesityTreatment #HealthCosts #AccessToMedication

It’s been a hot topic in health insurance since day one. Now an increasing number of self funded employers are covering GLP-1 drugs (ex: Ozempic and Wegovy) according to a recent survey. Take a look and learn about some key points to consider before covering these drugs on your plan.

The rising use of GLP-1 drugs for weight loss has been causing quite a stir for patients, health professionals, and benefit plans alike. Both employers and insurance carriers face challenges in creating guidelines for coverage of the drugs. See how employers can begin to develop their #GLP1 strategies. #employeebenefits #pharmacybenefits

As weight loss injections such as Ozempic become more popular, they prompt health concerns and legal actions due to off-label use. ⚠️ Victoria L. takes a closer look at the emerging risks for insurers. #MedicalLaw #Ozempic #Wegovy #WeightLossInjections #Medical #LifeSciences #WeightLoss #Insurance #InsuranceRPC #Insurers

The demand for anti-obesity drugs is building, but #health insurers and employers aren't yielding. Our survey results uncover the reasons why it may be harder to access weight-loss medications in 2024 via Business Insider. #recursoshumanos #talento #rrhh #humanresources #leadership #puertorico #mmc #mmb #consulting #risk #insurance #salud

Just when you thought you had seen everything it gets worse. Think about this situation and try to wrap your head around it. Payers (like UHC and Elevance/Anthem) are requiring Rheumatologist and other specialist to use certain biosimilar drugs to treat their patients. No that's the not insanity part. As much as having a payer decide what drug a patient gets is crazy this gets much worse. For some of those drugs the amount the carrier will pay the doctor for that drug is less than what the doctor had to pay to buy the drug. Let me say that again, the carrier makes you use a certain drug then pays you less than the cost of the drug. Yes, you got that right. So let me get this right. These huge, very profitable, insurance companies feel like they can tell doctors what drug to use and then make them provide that drug at below cost? Yup, that seems logical, said no one ever! https://lnkd.in/euughH4P

Concerned about prescription medication costs? Our conversation with Joanne Giardini-Russell revealed how the Inflation Reduction Act is changing the game. One client's insulin expenses dropped dramatically thanks to new caps on drug costs. Review your prescription drug plan annually to ensure it aligns with your current needs. #RetireToALifeYouLove #Medicare #DrugCosts #Insurance #HealthInsurance